IMF Videos Search Content For Healthcare Professional (76) Healthcare Provider (75) Care Partner (65) Patient (65) Series - Any - ASCO/EHA (31) ASH (30) Ask Dr. Durie (16) Community Workshops (3) Emerging Therapies (12) Facebook Live (6) Health Equity (4) IMWG (3) Living Well with Myeloma (3) Myeloma in a Minute (2) Myeloma Made Simple (6) Myeloma University (9) Q&A (6) Recent News and Developments (2) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (88) High-Risk Myeloma (38) High-risk Smoldering Myeloma (17) Late Relapse (4–6 Lines of Therapy) (101) MGUS (5) Newly Diagnosed (Pre-Treatment or First Treatment) (24) Smoldering Myeloma (13) Types of Therapy Immunomodulatory drugs (IMiDs) (31) Immunotherapies (CAR T; BiTE, etc.) (97) Monoclonal antibodies (33) Proteasome inhibitors (23) Stem cell transplant (24) Steroids (20) Supportive Care (36) Year Published 2026 (18) 2025 (22) 2024 (35) 2023 (39) 2022 (4) 2021 (4) 2020 (3) 2019 (2) 2018 (1) 2017 (1) 2016 (4) 2015 (2) Trusted Voices Dr. Joseph Mikhael (35) Dr. Brian GM Durie (15) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Donna Catamero, ANP-BC, OCN, CCRC (3) Dr. María-Victoria Mateos (2) Dr. Saad Usmani (2) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance IMF Conference Series - Highlights from ASCO, IMWG & EHA 2026 June 25, 2026 ASCO/EHA What Are Trispecific Antibodies in Multiple Myeloma? | Myeloma in a Minute June 4, 2026 Myeloma in a Minute What Happens After CAR T-Cell Therapy? Myeloma Experts Answer Common Questions May 21, 2026 Q&A Myeloma University | Managing BCMA Bispecifics in the Community April 24, 2026 Myeloma University Myeloma University | Managing CRS, Neurotoxicity, and Infection April 23, 2026 Myeloma University Myeloma University | Transitions of Care April 22, 2026 Myeloma University Can CAR-T Replace Stem Cell Transplant? Myeloma Questions on Cure, GLP-1s & Risk Answered April 16, 2026 Q&A Can You Get CAR T If You Live Alone? This and Other Myeloma Treatment Questions Answered | REPLAY April 7, 2026 Facebook Live Can Multiple Myeloma Be Cured? CAR T, Remission & Patient Questions Answered | REPLAY April 7, 2026 Facebook Live ASH 2025 Myeloma Update: Bispecific Antibodies & 3-Year Remission Data February 26, 2026 Recent News and Developments Top 5 CAR T-cell Therapy Breakthroughs from ASH 2025 February 18, 2026 Recent News and Developments Talquetamab + Teclistamab Show Promising Efficacy in Relapsed/Refractory Multiple Myeloma with EMD January 23, 2026 ASH Load More
